Yeah - Paratek a better lead bullet but not a silver one like our Brilacidin - the def-mimetic platform the Golden Gun platform. I do recall Leo saying they were looking into a pill version of B. Polymedix also ref'd trying to get this formulation too.

Below some addtl resources. The first article very in-depth on ABX trial design/CROs. I've sent to CTIX.

//

Antibiotic Development 2015: Less Can Be More
http://www.seca.ch/getattachment/d33e6fe7-061...-not-.aspx

//

Examination of Clinical Trial Costs and Barriers for Drug Development (July 2014)
[Eastern Research Group, which put this together, is the same consulting firm the DHS contracted for the Antibacterial Products mega-study posted a few months back... both chock-full of data]
http://aspe.hhs.gov/sp/reports/2014/ClinicalT...pt_erg.pdf

Analytical Framework for Examining the Value of Antibacterial Products (April 2014)
http://aspe.hhs.gov/sp/reports/2014/antibacte...erials.cfm

Changes in Clinical Trial Length (May 2015)
http://www.readcube.com/view/10.1038/nrd4611
Supplemental Information
http://www.nature.com/nrd/journal/v14/n5/extr...611-s1.pdf

Clinical Operations Cost Variation: Oncology vs. Non–Oncology
http://www.clinicalleader.com/doc/clinical-op...ology-0001